Innovation Data Science Predictive models Patient Finding

2021 08 WODC USA Presentation

Christopher M de M Rudolf
Accurate patient cohort identification

How we find the 50% of undiagnosed patients

An AI-based approach to drive earlier disease diagnosis and a case study

  1. Understand the burden of diagnosis for rare and heterogenous diseases from the clinician’s point of view.
  2. How we can make a difference with AI, to help ease the burden of misdiagnosis for all stakeholders, clinicians, and patients alike.
  3. Case study summary: presented at The International Society for Pharmacoepidemiology (ISPE), for Fabry disease in the Netherlands

Download the Presentation here:

Download PDF

 

Christopher M de M Rudolf

Follow me on my website Follow me on LinkedIn

Christopher is the Founder & CEO of Volv Global SA which is based in Lausanne, Switzerland. Volv is an applied data science company, that creates cutting edge approaches to solving difficult problems in healthcare and life sciences. He is passionate about innovation, thinking aloud/allowed, entrepreneurship and applying it in the healthcare and life science industry to help improve the well-being of people living with disease. He has over 30 years of experience as a technology entrepreneur and independent business advisor, having worked for many Blue-Chip organisations advising them on how to solve their critical global scale data problems. Interested in: Open-minded curious people, collaborative cross-disciplinary thinking, rare diseases, and next-generation healthcare.

Leave a Comment